abstract |
The present invention to 12-HETrE analogs which are agonists and antagonists of 12-HETrE. The compositions may be formulated in pharmaceutically acceptable formulations. The inventions also includes methods and products for treating inflammatory conditions, neovascularization, tumor growth, cancer, ischemic cardiovascular diseases, and ocular conditions. |